Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Prepaid Assets (2019 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Prepaid Assets for 13 consecutive years, with $47.8 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 246.76% to $47.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $47.8 million through Dec 2025, up 246.76% year-over-year, with the annual reading at $47.8 million for FY2025, 246.76% up from the prior year.
  • Prepaid Assets for Q4 2025 was $47.8 million at Madrigal Pharmaceuticals, down from $49.3 million in the prior quarter.
  • The five-year high for Prepaid Assets was $58.6 million in Q2 2025, with the low at $822000.0 in Q1 2021.
  • Average Prepaid Assets over 5 years is $13.6 million, with a median of $3.5 million recorded in 2021.
  • The sharpest move saw Prepaid Assets fell 20.46% in 2023, then skyrocketed 676.7% in 2024.
  • Over 5 years, Prepaid Assets stood at $1.3 million in 2021, then skyrocketed by 93.95% to $2.6 million in 2022, then increased by 21.39% to $3.2 million in 2023, then surged by 337.65% to $13.8 million in 2024, then soared by 246.76% to $47.8 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $47.8 million, $49.3 million, and $58.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.